Amy C. Cavers
Nessuna posizione attualmente
Profilo
Amy C.
Cavers held former positions as Senior Director-Global Strategic Marketing at Millennium Pharmaceuticals, Inc., Senior Director-Scientific Strategy at Onyx Therapeutics, Inc., Vice President-Scientific Affairs at TG Therapeutics, Inc., Vice President-Marketing at Celgene, Inc., Chief & SVP-Strategic Engagement at Verastem, Inc., and Vice President-Medical Affairs at Elevation Oncology, Inc. She completed her undergraduate degree at the University of Arizona.
Precedenti posizioni note di Amy C. Cavers
| Società | Posizione | Fine |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/02/2023 |
Celgene, Inc.
 Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Onyx Therapeutics, Inc.
 Onyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Onyx Therapeutics, Inc. discovers, develops and commercializes novel therapeutics. | Corporate Officer/Principal | - |
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Amy C. Cavers
| University of Arizona | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Celgene, Inc.
Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Health Technology |
Onyx Therapeutics, Inc.
Onyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Onyx Therapeutics, Inc. discovers, develops and commercializes novel therapeutics. | Health Technology |
- Borsa valori
- Insiders
- Amy C. Cavers
